Cargando…

Valuing life and evaluating suffering in infants with life-limiting illness

In this paper, we explore three separate questions that are relevant to assessing the prudential value of life in infants with severe life-limiting illness. First, what is the value or disvalue of a short life? Is it in the interests of a child to save her life if she will nevertheless die in infanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkinson, Dominic, Zayegh, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745707/
https://www.ncbi.nlm.nih.gov/pubmed/33331998
http://dx.doi.org/10.1007/s11017-020-09532-x
_version_ 1783624658887639040
author Wilkinson, Dominic
Zayegh, Amir
author_facet Wilkinson, Dominic
Zayegh, Amir
author_sort Wilkinson, Dominic
collection PubMed
description In this paper, we explore three separate questions that are relevant to assessing the prudential value of life in infants with severe life-limiting illness. First, what is the value or disvalue of a short life? Is it in the interests of a child to save her life if she will nevertheless die in infancy or very early childhood? Second, how does profound cognitive impairment affect the balance of positives and negatives in a child’s future life? Third, if the life of a child with life-limiting illness is prolonged, how much suffering will she experience and can any of it be alleviated? Is there a risk that negative experiences for such a child (suffering) will remain despite the provision of palliative care? We argue that both the subjective and objective components of well-being for children could be greatly reduced if they are anticipated to have a short life that is affected by profound cognitive impairment. This does not mean that their overall well-being will be negative, but rather that there may be a higher risk of negative overall well-being if they are expected to experience pain, discomfort, or distress. Furthermore, we point to some of the practical limitations of therapies aimed at relieving suffering, such that there is a risk that suffering will go partially or completely unrelieved. Taken together, these considerations imply that some life-prolonging treatments are not in the best interests of infants with severe life-limiting illness.
format Online
Article
Text
id pubmed-7745707
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-77457072020-12-18 Valuing life and evaluating suffering in infants with life-limiting illness Wilkinson, Dominic Zayegh, Amir Theor Med Bioeth Article In this paper, we explore three separate questions that are relevant to assessing the prudential value of life in infants with severe life-limiting illness. First, what is the value or disvalue of a short life? Is it in the interests of a child to save her life if she will nevertheless die in infancy or very early childhood? Second, how does profound cognitive impairment affect the balance of positives and negatives in a child’s future life? Third, if the life of a child with life-limiting illness is prolonged, how much suffering will she experience and can any of it be alleviated? Is there a risk that negative experiences for such a child (suffering) will remain despite the provision of palliative care? We argue that both the subjective and objective components of well-being for children could be greatly reduced if they are anticipated to have a short life that is affected by profound cognitive impairment. This does not mean that their overall well-being will be negative, but rather that there may be a higher risk of negative overall well-being if they are expected to experience pain, discomfort, or distress. Furthermore, we point to some of the practical limitations of therapies aimed at relieving suffering, such that there is a risk that suffering will go partially or completely unrelieved. Taken together, these considerations imply that some life-prolonging treatments are not in the best interests of infants with severe life-limiting illness. Springer Netherlands 2020-12-17 2020 /pmc/articles/PMC7745707/ /pubmed/33331998 http://dx.doi.org/10.1007/s11017-020-09532-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Wilkinson, Dominic
Zayegh, Amir
Valuing life and evaluating suffering in infants with life-limiting illness
title Valuing life and evaluating suffering in infants with life-limiting illness
title_full Valuing life and evaluating suffering in infants with life-limiting illness
title_fullStr Valuing life and evaluating suffering in infants with life-limiting illness
title_full_unstemmed Valuing life and evaluating suffering in infants with life-limiting illness
title_short Valuing life and evaluating suffering in infants with life-limiting illness
title_sort valuing life and evaluating suffering in infants with life-limiting illness
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745707/
https://www.ncbi.nlm.nih.gov/pubmed/33331998
http://dx.doi.org/10.1007/s11017-020-09532-x
work_keys_str_mv AT wilkinsondominic valuinglifeandevaluatingsufferingininfantswithlifelimitingillness
AT zayeghamir valuinglifeandevaluatingsufferingininfantswithlifelimitingillness